Clearside Biomedical Appoints Tony Gibney as New Chair
Portfolio - People | Nov 04, 2024 | EIN
Clearside Biomedical, a company focused on ophthalmic therapies using suprachoroidal delivery, has appointed Tony Gibney as Chair of its Board of Directors. The announcement reflects the company's strategic focus on strengthening leadership amidst its burgeoning product pipeline and partnerships. Gibney, who joined as an independent director earlier in 2024, brings extensive experience in biotechnology leadership and capital markets expertise, having held significant roles at Iveric Bio and Achillion Pharmaceuticals, and investment banking at Leerink Partners and Merrill Lynch. His leadership comes at a pivotal time as Clearside advances its lead program, CLS-AX, which has shown promising Phase 2b results for treating neovascular age-related macular degeneration (wet AMD). Gibney replaces Clay Thorp, who continues to serve on the board. Under Gibney's chairmanship, the company aims to expand its suprachoroidal delivery platform across multiple retinal diseases both independently and through strategic partnerships.
Sectors
- Biotechnology
- Healthcare
Geography
- United States – Clearside Biomedical is based in Alpharetta, Georgia, and operates primarily within the U.S. market.
Industry
- Biotechnology – The article discusses Clearside Biomedical, a company developing biotechnology solutions for ophthalmic conditions.
- Healthcare – Clearside Biomedical operates within the healthcare sector, focusing on innovation in therapeutic delivery platforms for eye diseases.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Clearside Biomedical, Inc. | Company | Target company | Clearside is a biopharmaceutical company focusing on suprachoroidal delivery of ophthalmic therapies. |
| Tony Gibney | Person | Chair of the Board of Directors | Newly appointed Chair of Clearside Biomedical, with extensive experience in biotechnology and investment banking. |
| Clay Thorp | Person | Former Chair, current Board Member | Former Chair of the Board, continuing as a member at Clearside Biomedical. |
| Iveric Bio, Inc. | Other Company | Company | Previous company where Tony Gibney served as Chief Business & Strategy officer. |
| Astellas Pharma Inc. | Other Company | Company | Acquirer of Iveric Bio, Inc., previous company of Tony Gibney. |
| Achillion Pharmaceuticals | Other Company | Company | A company previously sold to Alexion Pharmaceuticals by Tony Gibney, during his tenure. |
| Alexion Pharmaceuticals, Inc. | Other Company | Company | Acquired Achillion Pharmaceuticals, influenced by Tony Gibney. |